PRFX · PRF Technologies Ltd
United States · RS rating 9 · As of 2026-11-03
| Price | 0.71 USD |
|---|---|
| 1-day change | -5.2% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 22 / 16 / 6 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 11 / 3 / 1 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +87.7% |
| Market cap (USD) | $2.0M |